Open Label Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With ADHD.
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2012
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms Daytsleep
- 21 Dec 2011 Status changed from not yet recruiting to completed, as reported by Pediatric Neurology
- 01 Dec 2011 Results published in the Pediatric Neurology.
- 10 Oct 2009 New trial record